Industry / Bangladesh
API Park to Be Completed Next Year
April 2011 | Industry Trend AnalysisBMI View: Bangladesh has a very attractive, but fundamentally flawed pharmaceutical market. Combined sales of prescription and over-the-counter (OTC) drugs in the South Asian country saw the 16th fastest expansion in the world in 2010, at 21.9% - ahead of Tajikistan (+20.6%), but behind Turkmenistan (+22.5%). However, due to Bangladesh's patent-free regime, demand for medicines is artificially inflated and prejudiced against multinational firms. A deceleration of economic growth in 2011 and under-appreciated political risk are further disincentives to foreign direct
To read the full article, please choose one of the following options:
Subcribers please log in




